Moderna officer Stephen Hoge proposes $8.64M sale

The notice lists four earlier Stephen Hoge sales dated July 15, September 14, September 15, and October 14, 2026.

Rhea-AI Filing Summary

Moderna, Inc. (MRNA) officer Stephen Hoge reported a proposed sale of 39,145 common shares on October 15, 2026, through Fidelity Brokerage Services LLC. The listed aggregate market value is $8,640,032.55. The notice also lists four prior sales between July 15 and October 14, 2026.

Key Figures

Proposed sale: 39,145 shares Aggregate market value: $8,640,032.55 Shares outstanding: 399,235,889 shares +4 more

7 metrics

Proposed sale 39,145 shares Common shares; proposed sale date October 15, 2026

Aggregate market value $8,640,032.55 Proposed sale

Shares outstanding 399,235,889 shares Number listed in the securities information

Prior sale 53,336 shares; $3,605,513.60 Stephen Hoge sale on July 15, 2026

Prior sale 40,294 shares; $5,807,747.48 Stephen Hoge sale on September 14, 2026

Prior sale 40,281 shares; $5,883,708.71 Stephen Hoge sale on September 15, 2026

Prior sale 39,224 shares; $8,373,519.16 Stephen Hoge sale on October 14, 2026

Key Terms

Rule 144, Stock Option Exercise, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Option Exercise financial

"Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

attorney-in-fact regulatory

"as attorney-in-fact for Stephen Hoge"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Moderna (MRNA) shares does Stephen Hoge plan to sell?

Stephen Hoge reported a proposed sale of 39,145 common shares, with a listed aggregate market value of $8,640,032.55.

What earlier sales by Stephen Hoge are listed for Moderna (MRNA)?

The notice lists sales of 53,336 shares for $3,605,513.60 on July 15, 2026; 40,294 shares for $5,807,747.48 on September 14; 40,281 shares for $5,883,708.71 on September 15; and 39,224 shares for $8,373,519.16 on October 14, 2026.

How were the Moderna (MRNA) shares Stephen Hoge plans to sell acquired?

The shares are listed as acquired from the issuer through a stock option exercise for cash on October 15, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/15/2026 - 10:32 AM EDT Accepted by SEC EDGAR 10/15/2026 - 10:32 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001760669
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Moderna, Inc.
SEC File Number	001-38753
Address of Issuer	325 BINNEY STREET CAMBRIDGE MASSACHUSETTS 02142
Phone	6177146500
Name of Person for Whose Account the Securities are To Be Sold	Hoge Stephen
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	39145	8640032.55	399235889	10/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/15/2026	Stock Option Exercise	Issuer			39145	10/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Stephen Hoge 325 Binney Street Cambridge MA 02142	Common	07/15/2026	53336	3605513.60
Stephen Hoge 325 Binney Street Cambridge MA 02142	Common	09/14/2026	40294	5807747.48
Stephen Hoge 325 Binney Street Cambridge MA 02142	Common	09/15/2026	40281	5883708.71
Stephen Hoge 325 Binney Street, Cambridge MA 02142	Common	10/14/2026	39224	8373519.16

144: Remarks and Signature

Remarks
Date of Notice	10/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Stephen Hoge
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)